{"altmetric_id":10911164,"counts":{"readers":{"mendeley":16,"citeulike":0,"connotea":0},"total":{"posts_count":1},"twitter":{"unique_users_count":1,"unique_users":["fsgfon"],"posts_count":1}},"selected_quotes":["A look back: Impact of sorafenib dosing on outcome from a patient subset of the GIDEON"],"citation":{"altmetric_jid":"4f6fa63b3cf058f610008df2","authors":["Bruno Daniele"],"doi":"10.2217\/fon.15.163","endpage":"2562","first_seen_on":"2016-08-30T15:15:21+00:00","issns":["1479-6694","1744-8301"],"issue":"18","journal":"Future Oncology","last_mentioned_on":1472569832,"links":["http:\/\/www.futuremedicine.com\/doi\/full\/10.2217\/fon.15.163"],"pubdate":"2015-09-01T00:00:00+00:00","publisher_subjects":[{"name":"Oncology And Carcinogenesis","scheme":"era"}],"scopus_subjects":["Health Sciences","Medicine","Life Sciences","Biochemistry, Genetics and Molecular Biology"],"startpage":"2553","title":"Impact of sorafenib dosing on outcome from the European patient subset of the GIDEON study","type":"article","volume":"11","mendeley_url":"http:\/\/www.mendeley.com\/research\/impact-sorafenib-dosing-outcome-european-patient-subset-gideon-study"},"altmetric_score":{"score":0.5,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":0.5},"context_for_score":{"all":{"total_number_of_other_articles":8302052,"mean":6.9984430163018,"rank":6299457,"this_scored_higher_than_pct":13,"this_scored_higher_than":1123478,"rank_type":"exact","sample_size":8302052,"percentile":13},"similar_age_3m":{"total_number_of_other_articles":251588,"mean":12.499557536756,"rank":178482,"this_scored_higher_than_pct":16,"this_scored_higher_than":40356,"rank_type":"exact","sample_size":251588,"percentile":16},"this_journal":{"total_number_of_other_articles":736,"mean":4.2218639455782,"rank":456,"this_scored_higher_than_pct":18,"this_scored_higher_than":133,"rank_type":"exact","sample_size":736,"percentile":18},"similar_age_this_journal_3m":{"total_number_of_other_articles":54,"mean":20.87358490566,"rank":44,"this_scored_higher_than_pct":7,"this_scored_higher_than":4,"rank_type":"exact","sample_size":54,"percentile":7}}},"demographics":{"poster_types":{"science_communicator":1},"users":{"twitter":{"cohorts":{"Science communicators (journalists, bloggers, editors)":1}},"mendeley":{"by_status":{"Professor > Associate Professor":1,"Librarian":1,"Researcher":1,"Student  > Ph. D. Student":2,"Student  > Postgraduate":2,"Other":2,"Student  > Master":5,"Lecturer":1,"Unspecified":1},"by_discipline":{"Medicine and Dentistry":12,"Social Sciences":1,"Agricultural and Biological Sciences":2,"Unspecified":1}}}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/fsgfon\/statuses\/770639850005487616","license":"gnip","citation_ids":[10911164],"posted_on":"2016-08-30T15:10:32+00:00","author":{"name":"Future Oncology Jnl","url":"http:\/\/www.futuremedicine.com\/loi\/fon","image":"https:\/\/pbs.twimg.com\/profile_images\/489034431470911488\/VL6M5Pdz_normal.jpeg","description":"Future Oncology | MEDLINE-indexed journal on advances in basic, translational and clinical oncology research | IF 2.131 | Published by Future Science Group","id_on_source":"fsgfon","tweeter_id":"2647607972","geo":{"lt":null,"ln":null},"followers":1493},"tweet_id":"770639850005487616"}]}}